CN103272276A - Anal fistula suppository and preparation method thereof - Google Patents
Anal fistula suppository and preparation method thereof Download PDFInfo
- Publication number
- CN103272276A CN103272276A CN2013102035975A CN201310203597A CN103272276A CN 103272276 A CN103272276 A CN 103272276A CN 2013102035975 A CN2013102035975 A CN 2013102035975A CN 201310203597 A CN201310203597 A CN 201310203597A CN 103272276 A CN103272276 A CN 103272276A
- Authority
- CN
- China
- Prior art keywords
- biological
- anal fistula
- bolt
- preparation
- described step
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Abstract
The invention provides an anal fistula biological suppository and a preparation method thereof. The anal fistula biological suppository uses small intestine submucosa tissues of inbred line animals without cell and DNA (deoxyribonucleic acid) components as the raw material, completely reserves the extracellular matrix component and structure, and has a micropore structure. The preparation method of the anal fistula biological suppository comprises the following operation steps: determination of animal source, pretreatment and rough cleaning of small intestine tissues, virus inactivation, cell removal, DNA removal treatment, formation, packaging and sterilization. The anal fistula biological suppository prepared by the method uses an inbred line animal as an animal source, and thus, the hereditary features are pure, stable and uniform, thereby radically ensuring the stability and uniformity of different batches of products; and the anal fistula biological suppository has fewer animal source DNA residues, completely reserves the three-dimensional structure of natural ECM, and has the advantages of low immune source property and high infection resistance.
Description
Technical field
The present invention relates to animal derived implantation technical field of medical instruments, be specifically related to biological bolt of a kind of anal fistula and preparation method thereof.
Background technology
Anal fistula is the anal skin a kind of chronic infection pipeline identical with rectum/anal canal, is the inevitable outcome after the perianal abscess healing, is a kind of common anus benign disease, and incidence rate is only second to hemorrhoid and occupies second of optimum anal and intestinal disease.The main method for the treatment of anal fistula is surgical operation therapy.Traditional modus operandi comprises anal fistulectomy, ligating method for treating anal fistula, the spacious modus operandis such as drainage, per anum TRANSANAL RECTAL ADVANCEMENT FLAP of putting in fistula road, all there is the problem of anal function obstacle and recurrence in these operative treatment modes, the incidence rate of postoperative anal incontinence is between 10%～65%, postoperative anal fistula relapse rate is between 10%～20%, and patient's quality of life is very poor.Think that at present anal fistula healing and anal function protection all should be as treatment key of success indexs.Treatment biology of Wicresoft has become the main developing direction of anal fistula treatment.The biological fibrin glue filling is treatment means biology that occurs the earliest, but its success rate only has about 20%.2005, Cook Biotech Incorporated takes off (the small intestinal submucosa of cell pig intestinal mucosa lower floor, SIS) the host material product successfully is used for the anal fistula treatment, advantages such as this operation has that Wicresoft, patients ' life quality height, relapse rate are low, success rate reaches 60%, no anus dysfunction are the huge innovations of anal fistula operative treatment.
Based on the tissue engineering principle is that (extracellular matrix, ECM) material is the main developing direction of medical embedded material for the extracellular matrix of raw material with the animal tissue.ECM is by compositions such as multiple macromolecular substances such as collagen, non-collagen sugar albumen, aminoglycan, Dan Baijutang, elastin laminins, the organic three-dimension integrally of the complexity of building up with structure by a certain percentage, for the existence of various cells and movablely provide suitable place and microenvironment, can regulate growth, shape, metabolism, migration, propagation and the differentiation of various cells, and then regulation and control tissue and organ dysfunction.A forfeiture that serious consequence is " soil "-ECM of tissue defect, this also is the reason that body self can't be realized tissue repair and regeneration.Natural ECM can be used as tissue regeneration " soil ", is desirable tissue renovation material.Remove the cell component of animal tissue and can remove most immunogenicity, and keep the ECM composition, can develop desirable hernia patching material.Be used for clinical bioactive materials at present and comprised ECM materials such as allogeneic dermis, pig intestinal mucosa lower floor, pig dermis, embryo cattle corium.Wherein taking off cell submucous layer of small intestine host material is the optimal tissue renovation material that present academia is generally acknowledged.The anal fistula bolt of U.S. Cook Biotech Incorporated (trade name: Biodesign Surgisis) entered American-European countries market, and obtained clinical effectiveness preferably.
Biodesign Surgisis product has natural distinctive ECM structure and composition, initiatively induced tissue regeneration, and immunogenicity is low, and histocompatibility is good, advantages such as degradable.But along with the increase of clinical practice, the problem of Biodesign Surgisis product also displays.Clinical studies show: complication such as Biodesign Surgisis anal fistula bolt product has occurred in application that serosity in various degree swells, infects, comes off, chronic inflammatory reaction, organization healing are bad, wherein the swollen incidence rate of serosity is the highest.Complication may cause the recurrence of disease, even needs second operation to remove.In addition, the stability of the product of the anti-infection ability of product and different batches and uniformity are relatively poor.
On the one hand, the animal source DNA is residual is the major defect of Biodesign Surgisis product.The production technology of Biodesign Surgisis does not consider and removes the residual link of DNA that its product standard is not stipulated the content (reference standard: YZB/USA 0944-2010) of the residual control of DNA yet.Study verifiedly, serosity is swollen to be caused by the reaction of Th2 inflammatory cytokine, and this reaction is caused by the chronic immunoreation of animal source DNA exactly.On the other hand, Biodesign Surgisis product adopt common hybridization be pig as animal sources, hybridization is unstability and the heterogeneity that the individual variation of animal genetic background has caused the different batches product.Again on the one hand, the vacuum pressing lyophilizing moulding process that Biodesign Surgisis product adopts makes the space structure compression of SIS host material, has destroyed natural ECM three dimensional structure, influences the anti-infection ability of product and promotes the tissue regeneration ability.
Summary of the invention
Technical problem to be solved by this invention provides the biological bolt of a kind of anal fistula, the biological bolt of this anal fistula with the inbred line animal as animal origin, inherited characteristic is pure, stable, unified, in the stability and the uniformity that have fundamentally guaranteed the different batches product, the residual few and complete three dimensional structure that keeps natural ECM of animal source DNA, immunogenicity is low, and anti-infection ability is strong.
The biological bolt of a kind of anal fistula, it adopts the submucous layer of small intestine of inbred line animal to be organized as raw material, removes cell component and DNA composition, complete reservation extracellular matrix components and structure, and have microcellular structure.
Described inbred line animal is preferably inbred pig, more preferably Chinese inbred line WZSP.
The DNA residual quantity is 105 ~ 130pg/g behind described removal cell component and the DNA composition.
The aperture of described microcellular structure is 150 ~ 250um, and porosity is 85 ~ 90%.
The biological bolt of described anal fistula is rolled into taper shape or is pressed into bar shaped by 8 ~ 12 layers of monolayer material by 2 ~ 4 layers of monolayer material axle, and has the penetrability aperture, and the aperture of described penetrability aperture is 0.5 ~ 2mm, and span is 0.5 ~ 1cm.
Described penetrability aperture is for forming by the punching of laser micropore technology.
Another technical problem to be solved by this invention provides the preparation method of the biological bolt of above-mentioned anal fistula, this preparation method is improved and has been optimized preparation technology, increase DNA and removed link, with mechanical oscillation and the effective combination of supersonic oscillations, with Freeze Drying Technique and the effective combination of laser micropore technology, thereby effectively removed the animal source DNA, complete structure and the composition that has kept natural ECM, the biological bolt of anal fistula of the present invention is compared with existing similar products, the DNA residual quantity is low, and immunogenicity is low, anti-infection ability is high.
The preparation method of the biological bolt of above-mentioned anal fistula comprises following operating procedure:
(1) zoogenously determines and pre-process and the previous cleaning of small intestine
Select the inbred line animal as animal origin, the method for definite employing patent ZL200510008994.2 defined of animal varieties, cleaning is cleaned by the small intestine of getting fresh slaughtered animals, isolates submucous layer of small intestine, uses water for injection flushing 3 times.
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, this step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, wherein the volumn concentration of peracetic acid is that 0.05 ~ 0.2%(is preferably 0.1%), inactivation time is that 1 ~ 2h(is preferably 1h), temperature range is 4 ~ 40 ℃, in phosphate buffer, clean then 2 ~ 5 times, each 15min, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following.
(3) take off cell
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, at first material is inserted in the rinse bath, in rinse bath, inject sodium hydroxide solution then, open washer, scavenging period is that 5 ~ 30min(is preferably 20min), concentration of sodium hydroxide solution is that 5 ~ 100mmol/L(is preferably 5 ~ 20mmol/L, 10mmol/L more preferably), close washer then, sodium hydroxide solution is inclined to, inject phosphate buffer and clean, open washer, scavenging period is that 5 ~ 20min(is preferably 15min), phosphate buffer repeated washing 2 ~ 5 times, the pH value of the phosphate buffer after detection is cleaned is after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following.
(4) DNA removes and handles
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, sodium chloride solution is injected rinse bath, open washer, scavenging period is that 5 ~ 30min(is preferably 20min), concentration of sodium chloride solution is that 0.015mol/l or 2mol/L(are preferably 0.015mol/L), pH value is no more than 7.8, water for injection cleaning material to flow then detects electrical conductivity and reaches 1.5um/s termination when following.
(5) molding
This step comprises that fixture fixes, lyophilization and 3 steps of laser micropore punching, 2 ~ 4 layers of axle of material are rolled into taper shape (as shown in Figure 1) or 8 ~ 12 laminations are made bar shaped (as shown in Figure 2), be fixed on the fixture (being preferably the rustless steel fixture), clean clean then with water for injection, the material that is fixed in fixture is put in the freezer dryer, lyophilizing flow process according to design is in advance carried out lyophilization: pre-freeze to 25 ~ 50 ℃ (being preferably 25 ℃), be incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 15 ℃, be incubated 4 ~ 12 hours (being preferably 8h), heat up 15 ℃, be incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 25 ℃, be incubated 4 hours, after lyophilizing is finished, use laser micropore puncher punching (being the penetrability aperture), pore diameter range is 0.5 ~ 2mm, and span is 0.5 ~ 1cm.Described laser micropore punching refers to utilize laser technology that material is got micron-sized aperture, and using the punching of laser micropore puncher is in order to make material surface form hole, to be beneficial to tissue repair.
(6) packaging sterilizing
Pack under aseptic state, one deck adopts special strong defensive QI paper, another layer employing vinyon, adopts oxirane to sterilize after packing is finished.
The inbred line animal is preferably inbred pig in the described step (1), more preferably Chinese inbred line WZSP.Described Chinese inbred line WZSP refers to the animal varieties that ZL02149030.9 provides, and utilizes brood public female Wuzhi Mountain pig for being the ancestral, adopts " son joins mother ", " full ", the inbred pig population of cultivating.
As preferably, rinse bath frequency of oscillation is 100 ~ 300rpm, more preferably 200rpm in described step (2), (3), (4).
As preferably, ultrasonic frequency is 20 ~ 80KHZ, more preferably 45KHZ in described step (2), (3), (4).
The compound method of phosphate buffer described in the present invention is for claiming 7.9g NaCl, 0.2g KCl, 0.24g KH
2PO
4, 1.8g K
2HPO
4, be dissolved in the 800 ml distilled water, with the pH value to 7.4 of HCl regulator solution, adding distil water is settled to 1 L then.
The use standard of water for injection is according to stipulating in the state-promulgated pharmacopoeia among the present invention.
The ultrasonic washing unit that rinse bath described in the present invention can vibrate is that the rinse bath with the conventional ultrasonic wave cleaning machine combines with mechanical oscillator, make rinse bath that machinery concussion can take place in ultrasonic waves for cleaning, realized that mechanical oscillation and ultrasonic waves for cleaning are united simultaneously to play a role.
Compared with prior art, the present invention has following remarkable advantage and beneficial effect:
The present invention selects for use the inbred line animal as animal origin, after further being preferably Chinese inbred line WZSP, make the coefficient of inbreeding of this kind up to 0.991, the gene high homogenous, has pure, stable, the unified advantage of inherited characteristic, in the stability and the uniformity that have fundamentally guaranteed the different batches product, make the genetic background difference between the individuality very little, thereby determined immunogenic gene and the mankind to have very high homology.Be that uniformity, stability and the low immunogenicity of the submucous layer of small intestine ECM material product of animal origin exploitation be higher than to hybridize with this kind be that pig is the product of raw material.
Preparation method of the present invention is improved and has been optimized preparation technology, has increased DNA and has removed link, has determined the standard that product dna is residual.Inactivation of virus of the present invention adopts low concentration peracetic acid-alcoholic solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, taking off cell adopts low-concentration sodium hydroxide solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, DNA removes and adopts sodium chloride solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, all adopts phosphate buffer and water for injection to clean after every step is finished.Inactivation of virus in the preparation method, take off step such as cell and DNA removing all simultaneously in conjunction with mechanical oscillation and ultrasonic waves for cleaning, preparation method is with mechanical oscillation and the effective combination of supersonic oscillations, improved inactivation of virus, take off the efficient of cell and DNA removing technology, the DNA residual quantity significantly reduces, it is consuming time to greatly reduce technology, simplified technological process, whole process of preparation is only used peracetic acid-ethanol, three kinds of solution of sodium hydroxide and sodium chloride, and concentration is all well below the existing preparation technology, make the material of preparation remove immunogenicity fully, effective ingredient such as the complete structure that has kept natural ECM and somatomedin, no poisonous and harmful substance is residual, biocompatibility is good, avirulence, no teratogenecity, implant the no immunoreation in back; And, in moulding process, innovatively with Freeze Drying Technique and the effective combination of laser micropore technology, keeping natural ECM three dimensional structure, hole does not compress, the anti-infection ability height of product.
Description of drawings
Shown in Figure 1 is the structural representation of the biological bolt of the conical anal fistula of the present invention;
Shown in Figure 2 is the structural representation of the biological bolt of bar shaped anal fistula of the present invention;
The sample that shown in Figure 3 is in the embodiment of the invention 2 is cut out sketch map;
The optical microscope figure that shown in Figure 4 is in the embodiment of the invention 2;
The Electronic Speculum ultrastructure figure that shown in Figure 5 is in the embodiment of the invention 2.
The specific embodiment
Be further described in detail below in conjunction with the present invention of embodiment, but be not limited to this.
The preparation of the biological bolt of embodiment 1:4 layer anal fistula
Preparation method is as follows:
(1) zoogenously determines and pre-process and the previous cleaning of small intestine
Select Chinese inbred line WZSP as animal origin, the method of definite employing patent ZL200510008994.2 defined of animal varieties, the small intestine of getting fresh Chinese inbred line WZSP of butchering cleans clean, isolate submucous layer of small intestine, use water for injection flushing 3 times.
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, this step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, wherein the volumn concentration of peracetic acid is that 0.05 ~ 0.2%(is preferably 0.1%), inactivation time is that 1 ~ 2h(is preferably 1h), temperature range is 4 ~ 40 ℃, in phosphate buffer, clean then 2 ~ 5 times, each 15min, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following.The rinse bath frequency of oscillation is that 100 ~ 300rpm(is preferably 200rpm), ultrasonic frequency is that 20 ~ 80KHZ(is preferably 45KHZ).
(3) take off cell
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, at first material is inserted in the rinse bath, in rinse bath, inject sodium hydroxide solution then, open washer, scavenging period is that 5 ~ 30min(is preferably 20min), concentration of sodium hydroxide solution is that 5 ~ 100mmol/L(is preferably 5 ~ 20mmol/L, 10mmol/L more preferably), close washer then, sodium hydroxide solution is inclined to, inject phosphate buffer and clean, open washer, scavenging period is that 5 ~ 20min(is preferably 15min), phosphate buffer repeated washing 2 ~ 5 times, the pH value of the phosphate buffer after detection is cleaned is after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following.The rinse bath frequency of oscillation is that 100 ~ 300rpm(is preferably 200rpm), ultrasonic frequency is that 20 ~ 80KHZ(is preferably 45KHZ).
(4) DNA removes and handles
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, sodium chloride solution is injected rinse bath, open washer, scavenging period is that 5 ~ 30min(is preferably 20min), concentration of sodium chloride solution is that 0.015mol/l or 2mol/L(are preferably 0.015mol/L), pH value is no more than 7.8, water for injection cleaning material to flow then detects electrical conductivity and reaches 1.5um/s termination when following.The rinse bath frequency of oscillation is that 100 ~ 300rpm(is preferably 200rpm), ultrasonic frequency is that 20 ~ 80KHZ(is preferably 45KHZ).
(5) molding
This step comprises that fixture fixes, lyophilization and 3 steps of laser micropore punching, 4 layers of axle of material are rolled into taper shape, be fixed on the rustless steel fixture, clean clean then with water for injection, the material that is fixed in fixture is put in the freezer dryer, and carry out lyophilization according to the lyophilizing flow process of design in advance: pre-freeze to 25 ~ 50 ℃ (being preferably 25 ℃) is incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 15 ℃, be incubated 4 ~ 12 hours (being preferably 8h), heat up 15 ℃, be incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 25 ℃, be incubated 4 hours, after lyophilizing is finished, use the punching of laser micropore puncher, pore diameter range is 0.5 ~ 2mm, and span is 0.5 ~ 1cm.Described laser micropore punching refers to utilize laser technology that material is got micron-sized aperture, and using the punching of laser micropore puncher is in order to make material surface form hole, to be beneficial to tissue repair.
(6) packaging sterilizing
Pack under aseptic state, one deck adopts special strong defensive QI paper, another layer employing vinyon, adopts oxirane to sterilize after packing is finished.
Embodiment 2: the physicochemical property of the material that embodiment 1 is prepared, histology, somatomedin and biology performance detect
1. porosity measurement
Porosity measurement: adopt mercury injection method to measure the porosity of material, and with and compare with Biodesign Surgisis product.The porosity of the sample that result: embodiment 1 provides is that 87.8 ± 2.51, Biodesign Surgisis product porosity is 78.3 ± 6.38.
2. chemical property detects, and test item comprises virus, acid-base value, endotoxin and DNA residual quantity.
1) test liquid preparation: test liquid preparation: the thickness uniform parts of sample thief, be cut into 1cm
2Fragment, dry after washing, add then in the glass container, press the inside and outside total surface area (cm of sample
2) with the ratio of water (mL) be that the ratio of 5:1 adds water, add a cover to be placed in the pressure steam sterilizer, at 121 ℃ ± 1 ℃ heating 30min, with sample and fluid separation applications, be chilled to room temperature as test liquid after heating finishes.Get consubstantiality hydrops and place glass container, be equipped with blank liquid with legal system.
2) virus detects: method: the selection Pseudorabies virus is indicator virus, adopts the real-time quantitative PCR method to detect the viral DNA copy number, detects 3 batch samples.Result: viral DNA copy number 0.
3) acid-base value detects: press 5.4.1(among the GB/T14233.1 " medical infusion, blood transfusion, instrument used for injection method of inspection part 1: chemical analysis method ") the middle method test of stipulating, the result: the difference of the pH value of test liquid and blank liquid is no more than 1.5.
4) endotoxin: press 6cm
2Sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 ℃, 72 ± 2hr prepares experimental liquid, lixiviate medium: normal saline.By GB/T 14233.2-2005(" medical infusion, blood transfusion, instrument used for injection method of inspection part 2: biological test method ") regulation method carry out, detect 3 batch samples.The result: endotoxin content is less than 5EU/g.
5) the DNA residual quantity detects: according to biological preparation residual DNA detection method (" Chinese pharmacopoeia 2010, the exogenous DNA determination of residual amount of appendix IX-B method), adopt fluorescent staining method to detect the DNA residual quantity of the sample that embodiment 1 provides, and compare with Biodesign Surgisis product.The DNA residual quantity of the sample that result: embodiment 1 provides is 120 ± 15pg/g, and the DNA residual quantity of Biodesign Surgisis product is 250 ± 45pg/g.
3. histology
1) observation by light microscope: method: the capable hematoxylin of the material behind the paraffin peplos-Yihong dyeing, inverted phase contrast microscope is observed.The result: acellular residual with cell debris, the micro-continuous non-cracking of collagen, as shown in Figure 4.
2) Ultrastructural observation.The result: material is loose structure, the fiber non-cracking, and the aperture is even, and mean pore size is 200um, and porosity is greater than 85%, as shown in Figure 5.
4. somatomedin detects:
Press 6cm
2Sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 ℃, 72 ± 2hr prepares experimental liquid, lixiviate medium: normal saline.Adopt the ELLISA method to detect lixiviating solution neutral and alkali somatomedin (bFGF) and VEGF (VEGF) content.The result: bFGF content is 121.8 ± 2.683ng/L, and VEGF content is 93.8 ± 3.033ng/L.
5. biology performance detects, and test item comprises cytotoxicity, delayed hypersensitivity, intradermoreaction.
1) cytotoxicity: method: press 6cm
2Sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 ℃, 24 ± 2hr prepares experimental liquid, the lixiviate medium: the MEM culture medium that contains serum.Get experimental liquid according to GB/T16886.5-2003(" medical apparatus and instruments biological assessment the tenth part: stimulate and the delayed hypersensitivity test ") in the test method of regulation test.The result: cell-cytotoxic reaction is less than or equal to 1 grade.
2) delayed hypersensitivity: method: press 6cm
2Sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 ℃, 72 ± 2hr prepares experimental liquid, and the lixiviate medium is normal saline and Oleum Gossypii semen.According to CB/T 16886.10-2005(" medical apparatus and instruments biological assessment the 10th part: stimulate and the delayed hypersensitivity test ") the test method regulation tests.Result: no delayed hypersensitivity.
3) intradermoreaction: press 6cm
2Sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 ℃, 72 ± 2hr prepares experimental liquid, and the lixiviate medium is normal saline and Oleum Gossypii semen.According to CB/T 16886.10-2005(" medical apparatus and instruments biological assessment the 10th part: stimulate and the delayed hypersensitivity test ") the test method regulation tests.The result: the difference that test specimen and solvent control are on average kept the score is less than 1.0.
The above embodiment of the present invention is can not be used for restriction the present invention to explanation of the present invention, and the implication suitable with claims of the present invention and any change in the scope all should be thought to be included in the scope of claims.
Claims (24)
1. the biological bolt of an anal fistula is characterized in that: adopts the submucous layer of small intestine of inbred line animal to be organized as raw material, removes cell component and DNA composition, and complete reservation extracellular matrix components and structure, and have microcellular structure.
2. the biological bolt of a kind of anal fistula according to claim 1, it is characterized in that: described inbred line animal is inbred pig.
3. the biological bolt of a kind of anal fistula according to claim 2, it is characterized in that: described inbred pig is Chinese inbred line WZSP.
4. the biological bolt of a kind of anal fistula according to claim 1, it is characterized in that: the DNA residual quantity is 105 ~ 130pg/g behind described removal cell component and the DNA composition.
5. the biological bolt of a kind of anal fistula according to claim 1, it is characterized in that: the aperture of described microcellular structure is 150 ~ 250um, porosity is 85 ~ 90%.
6. according to the biological bolt of the described a kind of anal fistula of claim 1-5, it is characterized in that: be rolled into taper shape or be pressed into bar shaped by 8 ~ 12 layers of monolayer material by 2 ~ 4 layers of monolayer material axle, and have the penetrability aperture, and the aperture of described penetrability aperture is 0.5 ~ 2mm, span is 0.5 ~ 1cm.
7. the biological bolt of a kind of anal fistula according to claim 6, it is characterized in that: described penetrability aperture is for forming by the punching of laser micropore technology.
8. the preparation method of the biological bolt of the described a kind of anal fistula of claim 1 is characterized in that comprising following operating procedure:
(1) zoogenously determines and pre-process and the previous cleaning of small intestine
Select the inbred line animal as animal origin, the method for definite employing patent ZL200510008994.2 defined of animal varieties, cleaning is cleaned by the small intestine of getting fresh slaughtered animals, isolates submucous layer of small intestine, uses water for injection flushing 3 times;
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, this step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, wherein the volumn concentration of peracetic acid is 0.05 ~ 0.2%, and inactivation time is 1 ~ 2h, and temperature range is 4 ~ 40 ℃, in phosphate buffer, clean then 2 ~ 5 times, each 15min, the pH value of the phosphate buffer after detection is cleaned is after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following;
(3) take off cell
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, at first material is inserted in the rinse bath, in rinse bath, inject sodium hydroxide solution then, open washer, scavenging period is 5 ~ 30min, concentration of sodium hydroxide solution is 5 ~ 100mmol/L, closes washer then, and sodium hydroxide solution is inclined to, injecting phosphate buffer cleans, open washer, scavenging period is 5 ~ 20min, phosphate buffer repeated washing 2 ~ 5 times, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material that flows, detect electrical conductivity and reach 1.5um/s termination when following;
(4) DNA removes and handles
This step is carried out in the thermostatic ultrasonic ripple washer that rinse bath can vibrate, sodium chloride solution is injected rinse bath, open washer, scavenging period is 5 ~ 30min, concentration of sodium chloride solution is 0.015mol/l or 2mol/L, pH value is no more than 7.8, the water for injection cleaning material to flow then, detects electrical conductivity and reaches 1.5um/s termination when following;
(5) molding
This step comprises that fixture fixes, lyophilization and 3 steps of laser micropore punching, 2 ~ 4 layers of axle of material are rolled into taper shape or 8 ~ 12 laminations are made bar shaped, be fixed on the fixture, clean clean then with water for injection, the material that is fixed in fixture is put in the freezer dryer, carries out lyophilization according to the lyophilizing flow process of design in advance: pre-freeze to 25 ~ 50 ℃ are incubated 0.5 ~ 4 hour), be warming up to 15 ℃, be incubated 4 ~ 12 hours, heat up 15 ℃, be incubated 0.5 ~ 4 hour, be warming up to 25 ℃, be incubated 4 hours, after lyophilizing is finished, use the punching of laser micropore puncher, pore diameter range is 0.5 ~ 2mm, and span is 0.5 ~ 1cm;
(6) packaging sterilizing
Pack under aseptic state, one deck adopts special strong defensive QI paper, another layer employing vinyon, adopts oxirane to sterilize after packing is finished.
9. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the inbred line animal is inbred pig in the described step (1).
10. the preparation method of the biological bolt of a kind of anal fistula according to claim 9, it is characterized in that: described inbred pig is Chinese inbred line WZSP.
11. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the volumn concentration of peracetic acid is 0.1% in the described step (2).
12. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: inactivation time is 1h in the described step (2).
13. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the scavenging period that with sodium hydroxide solution material is cleaned in the described step (3) is 20min.
14. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: concentration of sodium hydroxide solution is 5 ~ 20mmol/L in the described step (3).
15. the preparation method of the biological bolt of a kind of anal fistula according to claim 14, it is characterized in that: concentration of sodium hydroxide solution is 10mmol/L in the described step (3).
16. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the scavenging period that with phosphate buffer material is cleaned in the described step (3) is 15min.
17. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the sodium chloride solution scavenging period is 20min in the described step (4).
18. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: concentration of sodium chloride solution is 0.015mol/L in the described step (4).
19. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the rinse bath frequency of oscillation is 100 ~ 300rpm in described step (2), (3), (4).
20. the preparation method of the biological bolt of a kind of anal fistula according to claim 19, it is characterized in that: the rinse bath frequency of oscillation is 200rpm in described step (2), (3), (4).
21. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: ultrasonic frequency is 20 ~ 80KHZ in described step (2), (3), (4).
22. the preparation method of the biological bolt of a kind of anal fistula according to claim 21, it is characterized in that: ultrasonic frequency is 45KHZ in described step (2), (3), (4).
23. the preparation method of the biological bolt of a kind of anal fistula according to claim 8, it is characterized in that: the fixture in the described step (5) is the rustless steel fixture.
24. the preparation method of the biological bolt of a kind of anal fistula according to claim 8 is characterized in that: in the described step (5) in advance the lyophilizing flow process of design be: pre-freeze to 25 ℃, insulation 2h, be warming up to 15 ℃, insulation 8h heats up 15 ℃, insulation 2h is warming up to 25 ℃, is incubated 4 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310203597.5A CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310203597.5A CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103272276A true CN103272276A (en) | 2013-09-04 |
| CN103272276B CN103272276B (en) | 2015-04-22 |
Family
ID=49054963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310203597.5A Active CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103272276B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106419989A (en) * | 2015-08-11 | 2017-02-22 | 陕西瑞盛生物科技有限公司 | Biomaterial rolling device and rolling method |
| CN106419988A (en) * | 2015-08-11 | 2017-02-22 | 陕西瑞盛生物科技有限公司 | Fistula bolt rolling device preventing rolling adhesion and rolling method |
| CN107019642A (en) * | 2017-03-31 | 2017-08-08 | 华东理工大学 | A kind of sustained-release administration type embolism and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185774A (en) * | 2007-10-25 | 2008-05-28 | 王振军 | Preparation of medical bioavailability bracket material and uses thereof |
| CN101217987A (en) * | 2005-04-29 | 2008-07-09 | 库克生物科技公司 | Fistula graft with deformable sheet-form material |
| US20090054927A1 (en) * | 2007-08-23 | 2009-02-26 | Agnew Charles W | Fistula plugs and apparatuses and methods for fistula plug delivery |
| CN102389323A (en) * | 2005-04-29 | 2012-03-28 | 库克生物科技公司 | Volumetric grafts for treatment of fistulae and related methods and systems |
-
2013
- 2013-05-28 CN CN201310203597.5A patent/CN103272276B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101217987A (en) * | 2005-04-29 | 2008-07-09 | 库克生物科技公司 | Fistula graft with deformable sheet-form material |
| CN102389323A (en) * | 2005-04-29 | 2012-03-28 | 库克生物科技公司 | Volumetric grafts for treatment of fistulae and related methods and systems |
| US20090054927A1 (en) * | 2007-08-23 | 2009-02-26 | Agnew Charles W | Fistula plugs and apparatuses and methods for fistula plug delivery |
| CN101185774A (en) * | 2007-10-25 | 2008-05-28 | 王振军 | Preparation of medical bioavailability bracket material and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| 霍艳丽: "脱细胞羊膜与小肠黏膜下层促进大鼠皮肤缺损修复和血管形成", 《中国优秀硕士学位论文全文数据库》, no. 11, 15 November 2009 (2009-11-15), pages 10 - 1 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106419989A (en) * | 2015-08-11 | 2017-02-22 | 陕西瑞盛生物科技有限公司 | Biomaterial rolling device and rolling method |
| CN106419988A (en) * | 2015-08-11 | 2017-02-22 | 陕西瑞盛生物科技有限公司 | Fistula bolt rolling device preventing rolling adhesion and rolling method |
| CN106419988B (en) * | 2015-08-11 | 2019-04-12 | 陕西瑞盛生物科技有限公司 | A kind of fistula bolt rolling device and method for coiling for preventing from rolling adhesion |
| CN106419989B (en) * | 2015-08-11 | 2019-04-16 | 陕西瑞盛生物科技有限公司 | A kind of rolling device and method for coiling of biomaterial |
| CN107019642A (en) * | 2017-03-31 | 2017-08-08 | 华东理工大学 | A kind of sustained-release administration type embolism and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103272276B (en) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272274B (en) | Biological repair tablet for herniae and preparation method thereof | |
| CN107007886B (en) | A kind of biological tissue's host material, preparation method and its usage | |
| CN103272278B (en) | Method for preparing animal derived implantable medical biomaterial | |
| EP2968419B1 (en) | Molded placental tissue compositions and methods of making and using the same | |
| CN103079577A (en) | Process,tube and device for the preparation of wound healant composition | |
| CN106456837A (en) | Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix | |
| CN110975010B (en) | Placenta tissue matrix material and preparation method thereof | |
| CN103301508B (en) | Preparation method of medical cartilage support material | |
| CN101616698A (en) | The ECM material of the enhanced processing of component characteristic | |
| BR112013026200A2 (en) | method for preparing a fabric matrix, and tissue matrix composition | |
| CN107224617A (en) | A kind of hydrogel using spleen cell epimatrix as raw material and preparation method thereof | |
| CN102631708B (en) | Preparation method of pelvic floor patch composite biological material and product of preparation method | |
| US11529437B2 (en) | Biological tissue matrix material, preparation method therefor and use thereof in otological repair material | |
| CN105169486A (en) | Neural restoration material combined with acellular nerve application | |
| CN103272276B (en) | Anal fistula suppository and preparation method thereof | |
| CN103861151A (en) | Method for preparing acellular placenta substrate material | |
| CN107823710A (en) | A kind of cell epimatrix material of high bioactivity and its preparation method and application | |
| CN105963787A (en) | Preparation method of new biological patches | |
| CN103272275B (en) | Biological repair tablet for endocranium and preparation method thereof | |
| CN104189009B (en) | Vascularization promoting submucous layer of small intestine temperature sensing material and preparation method thereof | |
| CN103301507B (en) | Artificial biological tendon and preparation method thereof | |
| CN107007882A (en) | A kind of nerve repair material, preparation method and application | |
| CN108079363A (en) | A kind of kit and its application that cell processing is taken off for animal tissue | |
| CN113230454A (en) | Biological membrane capable of inducing bone regeneration and preparation method and application thereof | |
| CN108030914A (en) | A kind of Matrigel raw material and preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |